TY  - JOUR
AU  - Biankin, AV
AU  - Grimmond, SM
Y2  - 2021/04/22
Y1  - 2013/02/28
SN  - 1756-994X
UR  - http://hdl.handle.net/11343/269190
AB  - Large-scale cancer genome studies are unveiling significant complexity and heterogeneity even in histopathologically indistinguishable cancers. Differentiating 'driver' mutations that are functionally relevant from 'passenger' mutations is a major challenge in cancer genomics. While recurrent mutations in a gene provides supporting evidence of 'driver' status, novel computational methods and model systems are greatly improving our ability to identify genes important in carcinogenesis. Reimand and Bader have recently shown that driver gene discovery in discrete gene classes (in this case the kinome) is possible across multiple cancer types and has the potential to yield new druggable targets and clinically relevant leads.
LA  - English
PB  - BMC
T1  - Novel cancer drivers: mining the kinome
DO  - 10.1186/gm423
IS  - Genome Medicine: medicine in the post-genomic era
VL  - 5
IS  - 2
ER  -